Medical research

'Decoy' protein works against multiple SARS-CoV-2 variants

A drug treatment that acts as a decoy against SARS-CoV-2 was highly effective at preventing death and lung damage in humanized animal models of severe COVID-19 disease, according to a Nature Chemical Biology study from researchers ...

Diseases, Conditions, Syndromes

Breathlessness in patients with long COVID may signal heart problems

A small study has suggested that COVID-19 patients who continue to be short of breath during physical activity one year after recovering from the infection may have suffered heart damage. The research is presented today at ...

Diseases, Conditions, Syndromes

Mitigating lung damage, mortality due to SARS-CoV-2

In a new paper, researchers at the University of Illinois Chicago report that a drug approved for treating patients with autoimmune disease helped to prevent lung damage and death in mice infected with the SARS-CoV-2 virus, ...

Diseases, Conditions, Syndromes

Why do short-lived lung infections lead to long-lasting lung damage?

The deadliest time in a viral respiratory illness sometimes is actually after the virus is cleared from the body. Destructive processes that are set in motion during an infection crest in the weeks after the virus is defeated, ...

Diseases, Conditions, Syndromes

What drives severe lung inflammation in COVID-19?

A main feature of COVID-19 is lung inflammation and respiratory failure caused by an overexuberant immune response known as the cytokine storm. But why does the body produce such an excess of cytokine immune cells? New research ...

page 1 from 13